Jeff Cislini, SVP & General Counsel at Revolution Medicines, Inc. (RVMD), sold 765 shares at $207.32 ($159K) on 2026-09-25, disclosed to the SEC on 2026-09-29.
Scheduled sale ($159k) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |
| RVMD | SELL | 2026-01-23 | $105K | — | Filing → |